IET logo
header image

3rd International IET/SynbiCITE Engineering Biology Conference 2017

Synthetic biology driving industrial translation in the bioeconomy

12 – 13 December 2017 | IET London: Savoy Place

IET London: Savoy Place (logo) Continuous Professional Development CPD (logo)

Theme of the event

Attend the conference and hear about key themes including:

Synthetic genomics

Synthetic genomics is a nascent field of synthetic biology that uses aspects of genetic modification on pre-existing genetic material or artificial gene synthesis to create new DNA. Engineering DNA in this way will enable the generation of chemically-synthesized whole genomes or large parts of genomes predicted to offer great benefits by making possible new drugs, renewable chemicals and clean energy.


Modern biotechnology provides breakthrough industrial processes to manufacture products across a wide range of applications from advanced materials to medicines, new fuels to new foodstuffs.

Examples include new drugs to combat debilitating and rare diseases, more efficient use of biomass to reduce our environmental footprint, new agritech to feed the world, and safer, cleaner and more efficient industrial manufacturing processes that use less natural living resource and produce less waste by-products.

Process engineering with feedback, optimisation and control for scale-up and manufacturing

Synthetic biology is being used to access and expand nature's chemical diversity by using all the elements of engineering disciplines to design and manufacture new materials; engineering biology – the design, modelling, simulation and process engineering to include feedback systems and design optimisation with control systems management – is being developed to enable manufacturing-at-scale to reduce our dependence on non-renewable feedstocks.

Biosensors and detectors

Diagnosis of diseases remains a major technological problem of medical sciences; sensing contaminants in water, food and the environment is a growing global challenge.

Engineering biosensors is enabling more accurate and rapid diagnosis of disease and early detection of, for example, toxins in food and water; this is being applied to medical diagnosis where, for example, engineered biosensors combine biological molecules as the sensing and transducing elements to provide quantitative or semi-quantitative analytical data corresponding to the concentration of a specific biomarker.

DNA assembly, programming biology and CRISPR technology

Combining powerful biological tools to read and reassemble DNA (to ‘write’ DNA) – that is, ‘programming biology’ – using new techniques such as CRISPR technology offers major technological advances, for example, in creating cell models of genetic diseases and for the production of novel materials.

Design, modelling, characterisation, automation, programming biology and QA/QC

We are at the forefront of designing biological systems using engineering principles and digital descriptions of biological entities.

This will enable us to design biological systems that can be modelled and characterised so that we can use automated processes for manufacturing-at-scale with industrial standards of control and quality assurance.


Microfluidic technologies are powerful tools for reducing cost, time and workload; they can improve accuracy, increase precision and the speed and performance of analysis of biological and biochemical samples compared with traditional techniques.

As microfluidics technologies advance they will enable faster in-the-field and laboratory characterisation, give in-process control of manufacturing-at-scale processes and become part of a new realm of diagnostic devices.

Premium exhibitor


Early Bird Member - £325

Early Bird Non-member - £395

Standard Member - £375

Standard Non-member - £475

Faculty / Post Doc - £300

Student - £150